Loading...
XMAD
PRM
Market cap228mUSD
Jul 11, Last price  
11.50EUR
1D
-3.77%
1Q
19.54%
Jan 2017
29.21%
Name

Prim SA

Chart & Performance

D1W1MN
P/E
17.92
P/S
0.84
EPS
0.64
Div Yield, %
2.93%
Shrs. gr., 5y
-0.36%
Rev. gr., 5y
9.08%
Revenues
233m
+7.68%
71,953,99190,542,33291,630,05295,760,93795,496,61895,111,84091,446,38488,662,28387,000,32794,205,58299,227,781110,099,596121,272,878134,429,946150,998,844147,323,948168,512,431197,245,073216,510,625233,147,000
Net income
11m
-13.83%
5,710,8347,554,94710,060,2179,903,88910,034,9228,531,9608,908,8609,135,1439,634,2689,961,52710,702,84713,096,66213,897,88114,118,96311,218,1256,917,30117,422,5908,391,26812,672,57010,920,000
CFO
0k
P
000000000012,245,80611,596,29512,438,4136,574,479652,23725,958,90526,304,7934,889,666-31,245,0650
Dividend
Jul 17, 20240.2269 EUR/sh

Profile

Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
URL
https://www.prim.es/
IPO date
Jan 21, 1997
Employees
827
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
233,147
7.68%
216,511
9.77%
197,245
17.05%
Cost of revenue
120,526
136,911
128,850
Unusual Expense (Income)
NOPBT
112,621
79,600
68,395
NOPBT Margin
48.30%
36.76%
34.68%
Operating Taxes
3,417
4,353
2,482
Tax Rate
3.03%
5.47%
3.63%
NOPAT
109,204
75,247
65,913
Net income
10,920
-13.83%
12,673
51.02%
8,391
-51.84%
Dividends
(7,604)
(6,239)
(8,839)
Dividend yield
4.65%
3.51%
4.80%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
10,948
16,964
10,279
Long-term debt
7,552
15,226
18,576
Deferred revenue
2
550
Other long-term liabilities
2,141
1,295
2,924
Net debt
6,986
12,640
10,738
Cash flow
Cash from operating activities
(31,245)
4,890
CAPEX
(11,341)
(10,390)
Cash from investing activities
(7,593)
(4,204)
Cash from financing activities
(11,321)
30,369
FCF
112,254
63,156
48,934
Balance
Cash
13,749
13,248
14,941
Long term investments
(2,235)
6,301
3,176
Excess cash
8,724
8,255
Stockholders' equity
15,179
128,450
128,069
Invested Capital
149,573
143,819
136,399
ROIC
74.44%
53.71%
54.37%
ROCE
74.18%
51.37%
46.86%
EV
Common stock shares outstanding
17,012
17,010
17,060
Price
9.62
-7.94%
10.45
-3.24%
10.80
-25.77%
Market cap
163,659
-7.93%
177,757
-3.52%
184,244
-26.47%
EV
170,645
193,268
194,981
EBITDA
112,621
89,643
76,772
EV/EBITDA
1.52
2.16
2.54
Interest
774
826
281
Interest/NOPBT
0.69%
1.04%
0.41%